Joy Maulik, MSN, FNP-C, explains why a prostate cancer diagnosis should be seen as a change in direction, not an ending, and how patients can lean on education, their providers and caregivers.
|Videos|February 22, 2017
Changing Melanoma Treatment in 2017
Omid A. Hamid, M.D., of The Angeles Clinic and Research Institute and Jason J. Luke, M.D., of University of Chicago Medicine, share treatment approaches on the horizon for patients with melanoma.
Advertisement
Omid A. Hamid, M.D., of The Angeles Clinic and Research Institute and Jason J. Luke, M.D., of University of Chicago Medicine, share treatment approaches on the horizon for patients with melanoma.
Advertisement
Related to this article
Dr. Morana Vojnic answers common questions about brain cancer, including diagnosis, tumor types, treatment effects, recurrence and life after treatment begins.
Dr. Jacqueline Barrientos shares how a targeted therapy, a determined care team and a stranger’s generosity gave a 72-year-old man with hairy cell leukemia and kidney failure a second chance.
Dr. Robert Kreitman explains how CD22-targeted CAR T could help heavily pretreated patients.
An expert at ESMO 2026 explains how liquid biopsy and ESR1 testing can help guide treatment for people with HR-positive metastatic breast cancer.
Psychiatrist Dr. Yesne Alici of Memorial Sloan Kettering Cancer Center answers questions about family relationships during cancer, from asking for help to talking with children and friends.
After breast cancer at 30, Aisha shares her journey through motherhood, a double mastectomy, body image struggles and the challenges of survivorship.
Advertisement
Advertisement
Trending on CURE
1
Medicare to Cut Ostomy Suppliers to 8 Contracts: What Patients Need to Know
2
3 ESMO 2026 Results in Endometrial and Breast Cancer to Know
3
4 Long-Term Survival Results From ESMO 2026 Patients Should Know
4
3 Quality-of-Life Results From ESMO 2026 Patients Should Know
5